Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001685462-16-000001
Filing Date
2016-09-26
Accepted
2016-09-26 13:04:52
Documents
1
Effectiveness Date
2016-09-26
Items
Item 04: Rule 504(b)(1) (not (i), (ii) or (iii))

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9927
  Complete submission text file 0001685462-16-000001.txt   11021
Mailing Address 1 RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address 1 RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 (240) 403-4212
Shuttle Pharmaceuticals, Inc. (Filer) CIK: 0001685462 (see all company filings)

EIN.: 461747648 | State of Incorp.: MD | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-271270 | Film No.: 161901716